CD86 and non-small cell lung carcinoma: Research on non-small cell lung cancer (NSCLC) has shown that exosomes produced from tumor cells overexpressing Rab27a can promote DC maturation by upregulating MHC II and the CD80 and CD86 costimulatory markers.